Increase in brain-derived neurotrophic factor expression in early crack cocaine withdrawal

International Journal of Neuropsychopharmacology

Volumn 17, Issue 1, 2014, Pages 33-40

  Von Diemen, Lisia ^a   Kapczinski, Flavio ^a,b   Sordi, Anne Orgle ^a   De Magalhães Narvaez, Joana Correa ^a   Guimarães, Luciano Santos Pinto ^a   Kessler, Felix Henrique Paim ^a   Pfaffenseller, Bianca ^b   De Aguiar, Bianca Wollenhaupt ^b   De Moura Gubert, Carolina ^b   Pechansky, Flavio ^a,b  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Brain derived neurotrophic factor; crack cocaine dependence; neurobiology; neurotrophin; withdrawal

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BIOLOGICAL MARKER; COCAINE;

ADULT; ARTICLE; CLINICAL ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DRUG DEPENDENCE TREATMENT; ELISA KIT; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; WITHDRAWAL SYNDROME; BLOOD; CASE CONTROL STUDY; HOSPITALIZATION; YOUNG ADULT;

ADULT; BIOLOGICAL MARKERS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CASE-CONTROL STUDIES; COCAINE-RELATED DISORDERS; CRACK COCAINE; HOSPITALIZATION; HUMANS; MALE; SUBSTANCE WITHDRAWAL SYNDROME; YOUNG ADULT;

EID: 84888606776     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S146114571300103X     Document Type: Article

References (43)

1. Amorim P, Lecrubier Y, Weiller E, Hergueta T, Sheehan D (1998) DSM-IH-R Psychotic Disorders: procedural validity of the Mini International Neuropsychiatric Interview (MINI). Concordance and causes for discordance with the CIDI. Eur Psychiatry 13:26-34. (Pubitemid 28125974)
2. Angelucci F, Ricci V, Pomponi M, Conte G, Mathe AA, Attilio Tonali P, Bria P (2007) Chronic heroin and cocaine abuse is associated with decreased serum concentrations of the nerve growth factor and brain-derived neurotrophic factor. J Psychopharmacol 21:820-825. (Pubitemid 350029194)
3. Autry AE, Monteggia LM (2012) Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol Rev 64:238-258.
4. Bahi A, Boyer F, Chandrasekar V, Dreyer JL (2008) Role of accumbens BDNF and TrkB in cocaine-induced psychomotor sensitization, conditioned-place preference, and reinstatement in rats. Psychopharmacol (Berl) 199:169-182.
5. Chen PH, Huang MC, Lai YC, Chen PY, Liu HC (2012) Serum brain-derived neurotrophic factor levels were reduced during methamphetamine early withdrawal. Addict Biol 2012. doi: 10.1111/j.1369-1600.2012.00444.x.
6. Corominas-Roso M, Roncero C, Eiroa-Orosa FJ, Gonzalvo B, Grau-Lopez L, Ribases M, Rodriguez-Cintas L, Sanchez-Mora C, Ramos-Quiroga JA, Casas M (2012) Brain-derived neurotrophic factor serum levels in cocaine-dependent patients during early abstinence. Eur Neuropsychopharmacol 2012. pii: S0924-977X(12)00249-0. doi: 10.1016/j.euroneuro.2012.08.016.
7. Costa MA, Girard M, Dalmay F, Malauzat D (2011) Brain-derived neurotrophic factor serum levels in alcohol-dependent subjects 6 months after alcohol withdrawal. Alcohol Clin Exp Res 35:1966-1973.
8. Cunha AB, Frey BN, Andreazza AC, Goi JD, Rosa AR, Goncalves CA, Santin A, Kapczinski F (2006) Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes. Neurosci Lett 398:215-219. (Pubitemid 43673698)
9. Davis MI (2008) Ethanol-BDNF interactions: still more questions than answers. Pharmacol Ther 118:36-57.
10. de Lima MN, Presti-Torres J, Vedana G, Alcalde LA, Stertz L, Fries GR, Roesler R, Andersen ML, Quevedo J, Kapczinski F, Schroder N (2011) Early life stress decreases hippocampal BDNF content and exacerbates recognition memory deficits induced by repeated D-amphetamine exposure. Behav Brain Res 224:100-106.
11. Dias AC, Vieira DL, Gomes LS, Araujo MR, Laranjeira R (2011) Longitudinal outcomes among a cohort of crack users after 12 years from treatment discharge. J Addict Dis 30:271-280.
12. D'Sa C, Fox HC, Hong AK, Dileone RJ, Sinha R (2011) Increased serum brain-derived neurotrophic factor is predictive of cocaine relapse outcomes: a prospective study. Biol Psychiatry 70:706-711.
13. Filip M, Faron-Gorecka A, Kusmider M, Golda A, Frankowska M, Dziedzicka-Wasylewska M (2006) Alterations in BDNF and trkB mRNAs following acute or sensitizing cocaine treatments and withdrawal. Brain Res 1071:218-225. (Pubitemid 43255491)
14. Fumagalli F, Di Pasquale L, Caffino L, Racagni G, Riva MA (2007) Repeated exposure to cocaine differently modulates BDNF mRNA and protein levels in rat striatum and prefrontal cortex. Eur J Neurosci 26:2756-2763. (Pubitemid 350115522)
15. George O, Koob GF (2010) Individual differences in prefrontal cortex function and the transition from drug use to drug dependence. Neurosci Biobehav Rev 35:232-247.
16. George O, Le Moal M, Koob GF (2012) Allostasis and addiction: role of the dopamine and corticotropin-releasing factor systems. Physiol Behav 106:58-64.
17. Graham DL, Edwards S, Bachtell RK, DiLeone RJ, Rios M, Self DW (2007) Dynamic BDNF activity in nucleus accumbens with cocaine use increases self-administration and relapse. Nat Neurosci 10:1029-1037. (Pubitemid 47185197)
18. Henskens R, Garretsen H, Bongers I, Van Dijk A, Sturmans F (2008) Effectiveness of an outreach treatment program for inner city crack abusers: compliance, outcome, and client satisfaction. Subst Use Misuse 43:1464-1475.
19. Hilburn C, Nejtek VA, Underwood WA, Singh M, Patel G, Gangwani P, Forster MJ (2011) Is serum brain-derived neurotrophic factor related to craving for or use of alcohol, cocaine, or methamphetamine? Neuropsychiatr Dis Treat 7:357-364.
20. Huang EJ, Reichardt LF (2001) Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 24:677-736. (Pubitemid 32695243)
21. Huang MC, Chen CH, Liu SC, Ho CJ, Shen WW, Leu SJ (2008) Alterations of serum brain-derived neurotrophic factor levels in early alcohol withdrawal. Alcohol Alcohol 43:241-245. (Pubitemid 351676344)
22. Huang MC, Chen CH, Liu HC, Chen CC, Ho CC, Leu SJ (2010) Differential patterns of serum brain-derived neurotrophic factor levels in alcoholic patients with and without delirium tremens during acute withdrawal. Alcohol Clin Exp Res 35:126-131.
23. Kapczinski F, Vieta E, Andreazza AC, Frey BN, Gomes FA, Tramontina J, Kauer-Sant'anna M, Grassi-Oliveira R, Post RM (2008) Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neurosci Biobehav Rev 32:675-692.
24. Kessler F, Cacciola J, Alterman A, Faller S, Souza-Formigoni ML, Santos Cruz M, Brasiliano S, Pechansky F (2012) Psychometric properties of the sixth version of the Addiction Severity Index (ASI-6) in Brazil. Rev Bras Psiquiatr 34:24-33.
25. Kim DJ, Roh S, Kim Y, Yoon SJ, Lee HK, Han CS, Kim YK (2005) High concentrations of plasma brain-derived neurotrophic factor in methamphetamine users. Neurosci Lett 388:112-115. (Pubitemid 41206742)
26. Klein AB, Williamson R, Santini MA, Clemmensen C, Ettrup A, Rios M, Knudsen GM, Aznar S (2010) Blood BDNF concentrations reflect brain-tissue BDNF levels across species. Int J Neuropsychopharmacol 14:347-353.
27. Koob GF, Le Moal M (2008) Addiction and the brain antireward system. Annu Rev Psychol 59:29-53.
28. Koob GF, Volkow ND (2009) Neurocircuitry of addiction. Neuropsychopharmacol 35:217-238.
29. Lee BC, Choi IG, Kim YK, Ham BJ, Yang BH, Roh S, Choi J, Lee JS, Oh DY, Chai YG (2009) Relation between plasma brain-derived neurotrophic factor and nerve growth factor in the male patients with alcohol dependence. Alcohol 43:265-269.
30. Lu L, Dempsey J, Liu SY, Bossert JM, Shaham Y (2004) A single infusion of brain-derived neurotrophic factor into the ventral tegmental area induces long-lasting potentiation of cocaine seeking after withdrawal. J Neurosci 24:1604-1611. (Pubitemid 38240955)
31. McEwen BS (1998) Protective and damaging effects of stress mediators. N Engl J Med 338:171-179.
32. McGinty JF, Mendelson JE (2011) Is brain-derived neurotrophic factor a selective biomarker that predicts cocaine relapse outcomes? Biol Psychiatry 70:700-701.
33. McGinty JF, Whitfield TW Jr., Berglind WJ (2010) Brain-derived neurotrophic factor and cocaine addiction. Brain Res 1314:183-193.
34. Mendelson J, Baggott MJ, Flower K, Galloway G (2011) Developing biomarkers for methamphetamine addiction. Curr Neuropharmacol 9:100-103.
35. O'Brien CP, McLellan AT (1996) Myths about the treatment of addiction. Lancet 347:237-240. (Pubitemid 26035251)
36. Pae CU, Chiesa A, Porcelli S, Han C, Patkar AA, Lee SJ, Park MH, Serretti A, De Ronchi D (2012) Influence of BDNF variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophrenia. Neuropsychobiol 65:1-11.
37. Parvaz MA, Alia-Klein N, Woicik PA, Volkow ND, Goldstein RZ (2011) Neuroimaging for drug addiction and related behaviours. Rev Neurosci 22:609-624.
38. Rasmussen P, Brassard P, Adser H, Pedersen MV, Leick L, Hart E, Secher NH, Pedersen BK, Pilegaard H (2009) Evidence for a release of brain-derived neurotrophic factor from the brain during exercise. Exp Physiol 94:1062-1069.
39. Sartorius A, Hellweg R, Litzke J, Vogt M, Dormann C, Vollmayr B, Danker-Hopfe H, Gass P (2009) Correlations and discrepancies between serum and brain tissue levels of neurotrophins after electroconvulsive treatment in rats. Pharmacopsychiatry 42:270-276.
40. Shim SH, Hwangbo Y, Kwon YJ, Jeong HY, Lee BH, Lee HJ, Kim YK (2008) Increased levels of plasma brain-derived neurotrophic factor (BDNF) in children with attention deficit-hyperactivity disorder (ADHD). Prog Neuropsychopharmacol Biol Psychiatry 32:1824-1828.
41. Sinha R (2011) New findings on biological factors predicting addiction relapse vulnerability. Curr Psychiatry Rep 13:398-405.
42. Volkow ND, Wang GJ, Fowler JS, Tomasi D, Telang F (2011) Addiction: beyond dopamine reward circuitry. Proc Natl Acad Sci USA 108:15037-15042.
43. Whitfield TW Jr., Shi X, Sun WL, McGinty JF (2011) The suppressive effect of an intra-prefrontal cortical infusion of BDNF on cocaine-seeking is Trk receptor and extracellular signal-regulated protein kinase mitogen-activated protein kinase dependent. J Neurosci 31:834-842.